4
Changes in Ownership
Faeth Therapeutics, Inc. Filed Acc 0002111813-26-000010
President and CEO bought 2,806 shares at $19.76 ($55,447)
- President and CEO acquired 53,465 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Parikh Anand Kiran · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-06-22 | Purchase : show line 1 in the form | +2,806 | $19.76 | $55,447 | 764,234 | D |
| 2026-06-22 | Exercise or conversion : show line 2 in the form | +45,252 | $1.16 | $52,492 | 809,486 | D |
| 2026-06-22 | Exercise or conversion : show line 3 in the form | +8,213 | $1.16 | $9,527 | 817,699 | D |
| Open-market purchases · 2,806 sh · avg $19.76 · $55,447 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-06-22 | Exercise or conversion : show line 4 in the form Employee Stock Option (right to buy) | −45,252 | 91,632 | D |
| 2026-06-22 | Exercise or conversion : show line 5 in the form Employee Stock Option (right to buy) | −8,213 | 4,107 | D |
Loading xslF345X06/form4-06242026_100628.xml…